# The TARGET BP OFF-MED Trial

> **NCT03503773** · PHASE2 · COMPLETED · sponsor: **Ablative Solutions, Inc.** · enrollment: 350 (actual)

## Conditions studied

- Hypertension
- Hypertension,Essential

## Interventions

- **DRUG:** Alcohol
- **OTHER:** Sham control

## Key facts

- **NCT ID:** NCT03503773
- **Lead sponsor:** Ablative Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-24
- **Primary completion:** 2022-01-31
- **Final completion:** 2024-01-10
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03503773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03503773, "The TARGET BP OFF-MED Trial". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03503773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*